Medical Animation Market - Value chain and stakeholder analysis 2024

Medical Animation Market: Overview

Digitization and interactivity are pervading every facet of consumers’ lives and the medical industry, too, is not insulated from this change. With the broadband explosion giving birth to newer ways of consuming content, medical animation has become a rapidly growing market. Medical animation helps demonstrate complex medical procedures or the mechanism of action of drugs in a visually rich format. From helping patients understand how a particular procedure is performed to providing sales demos to medical devices salespersons, medical animation videos can be targeted at varied audiences.

Although medical animation was initially a niche area within the animation and graphics industry, it is now arousing the interest of various pharmaceuticals manufacturers, life sciences research firms, medical organizations, and med device manufacturers. This has also encouraged new firms – in both traditional and emerging markets – to step into this space in a bid to gain a greater share of market revenues.

Read Full Report: http://www.transparencymarketresearch.com/medical-animation-market.html

With a rising demand for interactive and three-dimensional medical and pharmaceutical media, the opportunities in the medical animation market are only growing in number. This report delves into the latest trends and opportunities that companies in the medical animation market need to focus on. How the latest developments in motion picture technology are impacting direction that the medical animation market takes is also explored in the report. By meticulously segmenting the market into smaller sections for a closer study of each facet of the market, the report offers an unmatched degree of detail in its analysis.

Global Medical Animation Market: Defining Trends and Drivers

The rise of the smartphone culture has unarguably been the most defining development impacting the global medical animation market. There will be well over 2 billion smartphone users in the world by the end of 2016, various estimates have shown. A sizeable percentage of these users will, at some point in time, consume content centered on surgical procedures, pharmaceutical drug action mechanism, or medical devices.

At the same time, the start-up culture in the healthcare and life sciences sectors has helped make medical animation a mainstream trend to a great extent. The need to present information in a visually appealing and informative format has been emphatically stressed on by the newer generation of healthcare companies, which has in turn created a new and exciting battleground for companies in the medical animation market.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12137

However, the premium charged by companies offering medical animation services is not helping the growth of this market. This is partly owing to medical animation still being regarded a specialized skill. A shortage of certified professionals in the medical animation industry further compounds this problem. However, with the level of medical literacy still being comparatively low in non-traditional and underserved markets, the demand for medical animation is expected to show a steady rise.

Global Medical Animation Market: Key Segments

The market for medical animation can be segmented based on the applications of this technology, by type of animation, and by end user. The most common applications of medical animation are for patient education, medical device or drug formula simulation, molecular or cellular animation, emergency care education, surgical training, and forensic reconstruction. The global medical animation market by type can be segmented into: 4D, 3D, 2D, and flash animation.

The key end users of medical animation include, but are not limited to: Pharmaceutical companies, life sciences and biological research companies, academic institutions, medical device manufacturers, hospitals and surgical centers, and others.

Request For Discount On This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=12137

Companies that are currently vying for a greater share of revenue in the global medical animation market include Xvivo Scientific Animation, Ghost Productions, Inc., Invivo Communications, Inc., Medmovie, Inc., and Elara Systems, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Blood Preparation Market grows with increasing requirement for blood during accidents and surgical procedures

Global Blood Preparation Market: Overview

Blood components refer to products derived from platelet-rich plasma or whole blood. Blood components such as platelets, plasma, red blood cells, and white blood cells are derived from blood by the process of phlebotomy or hemapheresis through the technique of differential centrifugation. These blood components are separated from whole blood in hospital laboratories and blood centers, and are administered to patients suffering from various diseases through transfusion. The whole blood is often collected and separated into major components before transfusion. However, automated collections are becoming increasingly popular nowadays and only blood components that are needed for transfusion are collected.

On the basis of product type, the global blood preparation market has been segmented into whole blood and blood components. While whole blood comprises platelets, plasma, red cells, and granulocytes, blood components constitute whole blood components, leukocyte reduced RBC, packed red cells, frozen plasma, and platelet concentrate. According to the antithrombotic and anticoagulant type, the blood preparation market has been divided into anticoagulants, fibrinolytics, and platelet aggregation inhibitors. Major application segments in the blood preparation market include renal impairment, thrombocytosis, and pulmonary embolism.

Read Full Report: http://www.transparencymarketresearch.com/blood-preparation-market.html

Global Blood Preparation Market: Drivers and Restraints

The growing demand for blood transfusion across emergency departments in hospitals has boosted the growth of the global blood preparation market. The rise in blood disorders such as thrombocytosis and the increasing requirement for blood during accidents and surgical procedures have supported the growth of the market.

According to the Centers for Disease Control and Prevention, conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE) lead to over 60,000 deaths in the U.S. every year. Various initiatives taken by the National Institutes of Health and other regulatory bodies to spread awareness about the complications associated with these conditions have also propelled the market’s growth.

However, during blood transfusion, the chances of transmission of diseases such as viral hemorrhagic fever, HIV, and Hepatitis B are high. This is the single major restraining factor impacting the growth of the global blood preparation market. The overall market has a significant opportunity to grow with the development of high speed technology to separate blood components without losing their activity. The introduction of new oral anticoagulants and the re-launch of drugs such as Urokinase, the growing demand for source plasma, and the need for specific blood components such as packed red blood cells will create new growth opportunities for the market.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12467

Global Blood Preparation Market: Region-wise Outlook

The global blood preparation market has been segmented into four key regions: Europe, Asia Pacific, North America, and Rest of the World. North America has been contributing significantly to the growth of the market owing to the presence of a robust healthcare infrastructure. In the U.S., the collection, preparation, storage, and transport of blood is regulated by the FDA. Other federal agencies are working toward the implementation of health insurance portability standards to achieve adequate reimbursement for blood components.

However, during the forecast period, the Asia Pacific blood preparation market is anticipated to expand rapidly due to various initiatives taken by governments, especially in countries such as India and China. The positive growth of the healthcare sector across Japan and Australia will also support the growth of the regional market.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=12467

Global Blood Preparation Market: Competitive Landscape

Some of the key players in the global blood preparation market are GlaxoSmithKline PLC, Pfizer Inc., Leo Pharma Inc., Celgene Corp, Sanofi Aventis, Baxter Healthcare Corp., Shandong East Chemical Industry Co., Bristol-Myers Squibb Co., and AstraZeneca Co. The blood preparation market worldwide is being driven by technology. As a result, market players are investing heavily in research and development to introduce novel and cost-effective drugs.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Live Cell Imaging Market - Latest Trends & Insights 2024

A market intelligence report by Transparency Market Research presents a comprehensive analysis of the global market for live cell imaging technologies.

The study of living cells with the help of detailed pictures produced by imaging systems such as microscopes and high content screening systems is called live cell imaging. Over the past few years, the use of LCI techniques across a number of research areas has consistently increased owing to the many benefits these techniques offer. LCI techniques are known to produce an enhanced view of a number of biological functions by giving insights into cellular dynamics of cellular processes.

Read Full Report: http://www.transparencymarketresearch.com/live-cell-imaging-market.html

LCI techniques are changing the way in which proteins, molecular interactions, cells, and a multitude of biological processes are studied. These techniques are aiding scientists to monitor in real time a variety of cellular structures and internal structures, thus providing a better understanding of dynamic processes and cellular structures, which is crucial for properly studying many aspects of cell biology.

The information compiled in the report finds huge scope in drug discovery, genetics, cytology, neurobiology, microbiology, and immunology. The rising adoption of LCI techniques in these fields, the rising popularity of high content screening technologies in the field of drug discovery, the rising prevalence of a number of cancers, and the rising volumes of funds by government bodies for cell-based research are driving the global market for LCI techniques.

However, certain factors such as the high cost of sophisticated screening systems and shortage of skilled professionals are hindering the overall development of the global live cell imaging market to a certain extent.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7688

The report segments the market on the basis of four criteria: product type, technology, application, and geography.

On the basis of product type, the market is segmented into consumables, equipment, and software. Live cell imaging equipment are further classified into cell analyzers, standalone systems, image capturing devices, and microscopes. Of these, the segment of microscopes currently holds the largest share of the overall market. The consumables segment is bifurcated into assay kits, reagents, and media. Of these, the segment of assay kits currently holds the largest share in the overall LCI consumables market.

Technology-wise, the global live cell imaging market is segmented into FRAP (Fluorescence recovery after photo bleaching), PALM (Photo activated localization microscopy), TD-FLIM (Time-domain Fluorescence Lifetime Imaging Microscopy), FRET (Forster resonance energy transfer), TIRF (Total internal reflection fluorescence microscopy), and MPE (multiphoton excitation microscopy). On the basis of application, the market is segmented into wound healing, angiogenesis, chemotaxis, and cell culture under flow.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=7688

The report also presents a detailed overview of the competitive landscape of the global live cell imaging market with the help of detailed business profiles and SWOT analysis of some of the key companies in the market, recent development, and analysis of activities such as mergers and acquisitions, etc.

Some of the key companies in the market are Leica Microsystems, Carl Zeiss AG, Nikon Corporation, Molecular Devices, LCC, Becton, Dickinson and Company, Thermo Fisher Scientific, PerkinElmer, Inc., Sigma-Aldrich Corporation, and GE Healthcare.

Global Demand for Acute Care Needleless Connectors Market

Conventional needle based I.V. catheters, administration sets, and syringes are used for intravenous administration of fluids. However, use of needle based IV systems give rise to needlestick injuries to healthcare workers leading increased incidences of blood borne infections. Therefore, needleless connectors were introduced in 1980s to enhance the safety of healthcare workers. As a result, rate of needlestick injuries decreased significantly in later years. However, eventually it was observed that the use of needleless connectors lead to augment the risk of catheter related blood stream infections. Thus, various designs and mechanisms are introduced to resolve the problems associated with needleless connectors and catheter related blood stream infections. Needleless connectors provide convenience to the nursing staff in administering medication and drawing blood from the attached catheter, thus, these products are widely used in healthcare settings such as acute care hospitals where intravenous administration of medication and blood withdrawal is necessary during the course of treatment offered.

The global acute care needleless connectors market has been segmented based on the type of mechanism. Positive fluid displacement connectors segment accounted for the largest market share of around 34% in 2013. Dominance of this segment was mainly attributed to low cost of the commercially available positive fluid displacement needleless connectors. However, suspected link of positive fluid displacement connectors with increased rate of catheter related blood stream infection is anticipated to limit the growth of this market during the forecast period from 2014 to 2020.

The commercially available needleless connectors are majorly of two types, simple and complex. Simple needleless connectors are less expensive as they have fewer parts compared to complex needleless connectors. In addition, simple connectors do not have internal moving parts thus offering straight fluid pathway. Whereas, complex connectors have internal mechanical valves that leads to non-straight fluid pathway. Complex needleless connectors market was dominant in terms of revenue in 2013 majorly due to higher cost of these devices and large availability of products with mechanical valves in the market. However, increasing incidences of catheter-related bloodstream infections (CRBSI) and catheter lumen occlusion due to the use of complex needleless connectors, the demand for simple needleless connectors is likely to grow rapidly during the forecast period between 2014 and 2020.

Based on dwell time, the global acute care needleless connectors market has been segmented into 7 days connectors and other than 7 days connectors. The other than 7 day needleless connectors segment is anticipated to grow at the highest CAGR during the forecast period. Since, these connectors are available at a cheaper rate and offer added credibility of reduced risk of CRBSI infection rate than the 7 day needleless connectors.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4230

Geographically, North America is leading the global acute care needleless connectors market. High awareness among healthcare practitioners, improved healthcare infrastructure and rapid growth in aging population are the major factors driving the market in North America. Furthermore, Asia Pacific is anticipated to show significant growth in the forecast period owing to increasing prevalence of chronic diseases, growing number of hospitals and healthcare facilities, and geographical expansion of market players in India, China, Southeast Asia, and Australia. Key players mapped in the report include, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, CareFusion Corporation, ICU Medical Inc., Nexus Medical LLC, RyMed Technologies LLC, and Vygon SA.

Expansion of Regional Markets to Drive the Asia Pacific Acute Care Needleless Connectors Market

Geographically, the global acute care needleless connectors market is segmented into Asia Pacific, North America, Europe, and Rest of the World. The global acute care needleless connectors market is dominated by North America owing to factors such as a rapidly growing geriatric population in this region, high quality healthcare infrastructure, and widespread awareness amongst healthcare professionals.

It is however, the Asia Pacific market that will expand substantially in the forthcoming years. Factors that propel the Asia Pacific acute care needleless connectors market are growing number of healthcare facilities and hospitals, high incidence of chronic ailments, and most importantly expansion of regional markets such as Australia, Southeast Asia, China, and India.

The prominent companies operating in the global acute care needleless connectors market are Vygon SA, RyMed Technologies LLC, Nexus Medical LLC, ICU Medical Inc., CareFusion Corporation, Becton Dickinson and Company, B. Braun Melsungen AG, and Baxter International Inc. High incidence of cases of catheter related blood stream infections hampers the growth of the global acute care needleless connectors market. Steep cost of branded products as against the domestic substitutes and local products is another factor restraining the market. High investments in a few of the emerging economies is likely to create lucrative growth opportunities in the global acute care needleless connectors market.

The Future Shape of Blood Collection Tubes Market

No matter how large a leap we may take in diagnostics, even the best diagnostic tests fail to deliver accurate results if the biological sample isn’t well preserved. This especially applies to blood samples as blood analysis is still an important part of diagnostics. However, it wasn’t until the introduction of evacuated blood collection tubes market that several diagnostic processes became faster and more precise. In the years that followed, several improvements have been made to tube materials, the additives used to perform specific functions on blood samples, and the overall design of such tubes.

North America has been at the forefront of several new developments reported in the global blood collection tubes market. According to a Transparency Market Research report, the North America blood collection tubes market is on course to reach a valuation of US$632.1 mn by 2023. The market approximated US$300.8 mn in 2014, the report says.

Request Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8689

Here are the top five highlights of the blood collection tubes market in North America

• The volume of blood collected in North America every year for medical purposes is staggering. In the United States alone, estimates show that over 18 mn units of blood is transfused annually to treat hematologic diseases.
• Tests on blood samples are vital to the timely diagnosis of potentially life-threatening diseases such as dengue, thalassemia, and even certain types of cancer. This is causing an uptick in the demand of blood collection tubes.
• The coverage of several diseases and conditions under new reimbursement plans in the United States has caused a spurt in the number of diagnostic tests conducted here annually, subsequently leading to higher demand for blood collection tubes.
• By type, the blood collection tubes market can be divided into rapid serum tubes, plasma separating tubes, heparin tubes, serum separating tubes, and other tubes. Of these, North America sees the highest demand for serum separating tubes. Canada and the United States are the two key markets in North America, of which the United States blood collection tubes market generates the highest revenue.
• There is a growing demand for tubes that are compatible with automated blood collection processes and more advanced screening tests. This is prompting manufacturers to improve the design of their existing products and bring easy-to-use blood collection tubes to the market.

However, the growth of the market will likely be restricted by to some degree by the high cost of investing in sophisticated blood testing equipment. Since the safety mechanism of blood collection tubes is of utmost importance, products with the highest safety specifications will naturally hold a competitive advantage over their counterparts on the market. Some of the leading companies in the North America blood collection tubes market are Becton, Dickinson & Company (U.S.), Sarstedt AG & Co. (Germany), Greiner Group AG (Austria), Terumo Corporation (Japan), QIAGEN N.V. (Germany), and FL Medical srl (Italy).

Hospital Acquired Disease Testing Market - Global Industry Analysis, Trends and Forecast 2015 - 2023

The United States Centers for Disease Control and Prevention (CDC) conducted a survey in 2011 in several hospitals across the country to assess the severity of hospital-acquired infections (HAI) and diseases, also known as nosocomial infection or healthcare-associated infection. The survey found that an estimated one in every 25 hospital patients was suffering from at least one form of hospital-acquired disease on any given day. In 2011 alone, approximately 75,000 patients in the US died from hospital-acquired infections while being hospitalized, with an estimated 722,000 new cases of HAI reported in acute care hospitals.

The hospital-acquired disease testing market is anticipated to witness impressive growth over the coming years. HAIs are a rather serious threat to patient safety and more often than not, these infections can be prevented if appropriate measures are taken in advance. Advancement in hospital care as well as public health, in addition to increased awareness among patients and healthcare providers alike, has fueled the demand for hospital-acquired disease testing.

Get Sample of Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1759

Performance of Hospital-Acquired Disease Testing Market over the Years

According to Transparency Market Research, the global hospital-acquired disease testing market is projected to present a remarkable 19.90% CAGR from 2015 to 2023, rising from a value of US$0.4 bn in 2014 to US$2 bn in 2023. The most prominent players competing in the global hospital-acquired disease testing market include Cepheid, Inc., bioMérieux SA, Hologic, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Abbott Laboratories, QIAGEN, Siemens Healthcare, Meridian Bioscience, Inc., Alere, Inc., Diatherix Laboratories, Inc., and F. Hoffmann-La Roche Ltd.

The hospital-acquired disease testing market has, over the years, been fueled by the rising prevalence of nosocomial infections, increase in the number of drug-resistant pathogens, establishment and implementation of government guidelines to prevent the spread of hospital-acquired infections, technological development in the field of molecular diagnostics, surge in awareness among the general population, rise in geriatric and neonatal population, and need to control healthcare expenditure. The passing of the Patient Care and Affordable Care Act in the United States is especially significant in the development of the hospital-acquired disease testing market. However, lack of effective programs, guidelines, and framework in less-developed regions threatens to impede the overall market.

North America Dominates Worldwide Market for Hospital-Acquired Disease Testing

The global hospital-acquired disease testing market comprises five key regional segments: Europe, Latin America, North America, Asia Pacific, and the Middle East and Africa. In 2014, North America dominated the overall market, followed by Europe. The hospital-acquired disease testing markets in these developed regions are primarily fueled by strong and effective government initiatives designed to prevent and control the spread of hospital-acquired infections. These steps are rigorously implemented in order to bring down the disease morbidity rate and ensuring maximum patient safety.

Browse Full Global Hospital Acquired Disease Testing Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/hospital-acquired-disease-testing.html

The most lucrative market for hospital-acquired disease testing, on the other hand, is Asia Pacific. The incidence rate of hospital-acquired infections in countries such as India and China is considerably high, hiking healthcare expenditure not just for the patient but for the healthcare institutions as well. The growing need to reduce these costs, accompanied by rise in awareness and growth of medical tourism is greatly responsible for the future development of the Asia Pacific hospital-acquired disease testing market.

Rising Prevalence of Needlestick Injuries Drive Demand for Acute Care Needleless Connectors: Market to Expand at 10.20% CAGR between 2014 and 2020

A recent market research study published by the market research company Transparency Market Research (TMR) examines the global market for acute care needleless connectors. The report projects that the market will expand at a healthy 10.2% CAGR between 2014 and 2020 and rise to a valuation of US$972.0 million by 2020.The report is titled “Acute Care Needleless Connectors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”.

Browse the full Acute Care Needleless Connectors Market (By Design Type: Simple and Complex; By Mechanism: Positive, Negative and Neutral Displacement; and By Dwell Time: 7 Days and Other than 7 Days) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 report at http://www.transparencymarketresearch.com/acute-care-needleless-connectors-market.html

The report states that the major driving forces behind the flourishing market for acute care needleless connectors are the rising global prevalence of needlestick injuries, rising global geriatric population, and the rise in incidences of chronic pain, diabetes, and cancer. However, the high cost of branded varieties of acute care needleless connectors and easy availability of substitutes are some of the key factors hindering the overall growth of the market. In addition to this, the high prevalence of catheter related bloodstream infections (CRBSI) is also expected to hinder the market’s growth to certain extent over the report’s forecast period.

Nevertheless, the rising investments for research and development in the field of needleless connectors in developing countries is expected to propel the global market for needleless connectors over the report’s forecast period.The report segments the global acute needleless connectors market on the basis of four broad criteria: design types, mechanism of action, dwell time, and key regional markets.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4230

Based on product design, the market is further segmented into simple acute needleless connectors and complex acute needleless connectors. Of these, the market for complex needleless connectors led the overall market in 2013 by acquiring more than half of the market shares. Over the report’s forecast period, however, the market for simple needleless connectors is expected to grow at the fastest pace.Based on the mechanism of action, the report segments the market into positive fluid displacement, neutral fluid displacement, and negative fluid displacement devices. Of these, the segment of positive fluid displacement devices held the largest share of the market in 2013. However, positive fluid displacement connectors carry a high risk of causing CRBSI, which can hamper the growth of this market segment to a certain extent over the report’s forecast period. This is, in turn, is expected to benefit the market segment of neutral fluid displacement connectors, allowing it to expand at an 11% CAGR over the report’s forecast period.

Read Full Press Release: http://www.transparencymarketresearch.com/pressrelease/acute-care-needleless-connectors-market.htm

Regionally, the market for acute care needleless connectors, which saw the highest growth is North America in 2013, is expected to expand at the fastest pace in Asia Pacific over the forecast period.The report also presents a comprehensive analysis of the competitive landscape of the global acute care needleless connectors market, wherein business profiles of some of the key businesses operating in the market are analyzed. The key vendors operating in the market include B. Braun Melsungen, Becton Dickinson and Co., Baxter Int. Inc., Nexus Medical, CareFusion Corp., ICU Medical Inc., Vygon SA, and RyMed Technologies.

The global market for acute care needleless connectors is segmented as:

Global Acute Care Needleless Connectors Market, by Design Types
Simple
Complex
Global Acute Care Needleless Connectors Market, by Mechanism
Positive Fluid Displacement
Negative Fluid Displacement
Neutral Fluid Displacement
Global Acute Care Needleless Connectors Market, by Dwell Time
7 Days
Other than 7 Days
Global Acute Care Needleless Connectors Market, by Geography
North America
By Design Type
Simple Connectors
Complex Connectors
By Mechanism
Positive Displacement
Negative Displacement
Neutral Displacement
By Dwell Time
Seven Day
Other than Seven Day
Europe
By Design Type
Simple Connectors
Complex Connectors
By Mechanism
Positive Displacement
Negative Displacement
Neutral Displacement
By Dwell Time
Seven Day
Other than Seven Day
Asia-Pacific
By Design Type
Simple Connectors
Complex Connectors
By Mechanism
Positive Displacement
Negative Displacement
Neutral Displacement
By Dwell Time
Seven Day
Other than Seven Day
Rest of the World
By Design Type
Simple Connectors
Complex Connectors
By Mechanism
Positive Displacement
Negative Displacement
Neutral Displacement
By Dwell Time
Seven Day
Other than Seven Day
Major geographies analyzed under this research report are:
Europe
North America
Asia-Pacific
Rest of the World

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Mr. Nachiket
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/ 

Rising Prevalence of Needlestick Injuries Drive Demand for Acute Care Needleless Connectors: Market to Expand at 10.20% CAGR between 2014 and 2020

High incidence of cancer, diabetes, and chronic pains drives the global market for acute care needleless connectors. Much of the demand for acute care needleless connectors also comes from the growing geriatric population and high incidence of needlestick injuries. The intravenous administration of fluids makes use of syringes, administration sets, and the conventional needle based IV catheters. But the problem with needle based IV systems is that it leads to needlestick injuries to most healthcare workers, which in turn increases the incidence of infections that are blood borne. In order to ensure the safety of healthcare workers, needleless connectors were first introduced in the 1980s. Thus, there was a dramatic decline in the incidence of needlestick injuries in the subsequent years. Later on it was observed that catheter related blood stream infections had increased because of needleless connectors. Several mechanisms and designs have been introduced in order to reduce the problems associated with catheters and needleless connectors.

The global acute care needleless connectors market is projected to expand at 10.2% CAGR from 2014 to 2020, thereby reaching US$972 million by the end of the forecast period.

Browse Full Article: http://www.transparencymarketresearch.com/article/acute-care-needleless-connectors-market.htm

Seven-day Needleless Connectors Market to Witness Robust Growth in the Forthcoming Years

The global acute care needleless connectors market is segmented on the basis of type of design, mechanism, dwell time, and geography. Based on design type, this market is categorized into complex needleless connectors and simple needleless connectors. The segment for complex needleless connectors was the fastest growing segment in 2013.

On the basis of mechanism, the global acute care needleless connectors market is segmented into neutral fluid displacement, negative fluid displacement, and positive fluid displacement. In 2013, the segment for positive fluid displacement held the largest share of the global market because of the low costs of positive fluid displacement needleless connectors that are available commercially.

Based on dwell time, the global acute care needleless connectors market is categorized into other than seven-day needleless connectors, and seven-day needleless connectors. It is anticipated that the seven-day needleless connectors segment will expand robustly during the forecast period.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4230

Expansion of Regional Markets to Drive the Asia Pacific Acute Care Needleless Connectors Market

Geographically, the global acute care needleless connectors market is segmented into Asia Pacific, North America, Europe, and Rest of the World. The global acute care needleless connectors market is dominated by North America owing to factors such as a rapidly growing geriatric population in this region, high quality healthcare infrastructure, and widespread awareness amongst healthcare professionals.

It is however, the Asia Pacific market that will expand substantially in the forthcoming years. Factors that propel the Asia Pacific acute care needleless connectors market are growing number of healthcare facilities and hospitals, high incidence of chronic ailments, and most importantly expansion of regional markets such as Australia, Southeast Asia, China, and India.

The prominent companies operating in the global acute care needleless connectors market are Vygon SA, RyMed Technologies LLC, Nexus Medical LLC, ICU Medical Inc., CareFusion Corporation, Becton Dickinson and Company, B. Braun Melsungen AG, and Baxter International Inc. High incidence of cases of catheter related blood stream infections hampers the growth of the global acute care needleless connectors market. Steep cost of branded products as against the domestic substitutes and local products is another factor restraining the market. High investments in a few of the emerging economies is likely to create lucrative growth opportunities in the global acute care needleless connectors market.

Browse Full Global Acute Care Needleless Connectors Market Report With Complete TOC @ http://www.transparencymarketresearch.com/acute-care-needleless-connectors-market.html

Contact us:

Mr. Nachiket
Transparency Market Research
90 State Street, 
Suite 700, 
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/